BioMarin Pharmaceutical, Inc. (BMRN)
60.43
+1.90
(+3.25%)
USD |
NASDAQ |
Mar 04, 16:00
59.68
-0.75
(-1.24%)
Pre-Market: 08:15
BioMarin Pharmaceutical Price : 60.43 for March 4, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amicus Therapeutics, Inc. | 14.33 |
| Gilead Sciences, Inc. | 148.22 |
| Merck & Co., Inc. | 120.28 |
| MannKind Corp. | 2.95 |
| AbbVie, Inc. | 236.19 |
Price Related Metrics
| PE Ratio | 33.92 |
| PS Ratio | 3.625 |
| Price to Book Value | 1.909 |
| Price to Free Cash Flow | 16.39 |
| Earnings Yield | 2.95% |
| Market Cap | 11.62B |
| Operating PE Ratio | 14.38 |
| Normalized PE Ratio | 18.98 |